The primary purpose of the organization is to provide comprehensive clinical care to persons affected by inherited blood disorders and to administer programs supported by federal grants awarded by the department of health and human services health resources services administration (HRSA) and by the centers of disease control (CDC), including grants related to hemophilia and sickle CELL disease.